PMID- 24498831 OWN - NLM STAT- MEDLINE DCOM- 20140227 LR - 20190907 IS - 1028-8880 (Print) IS - 1028-8880 (Linking) VI - 16 IP - 16 DP - 2013 Aug 15 TI - An MTHFR variant, plasma homocysteine levels and late-onset coronary artery disease in subjects from southern Iran. PG - 788-95 AB - There have been many controversial debates on the role of Hyperhomocysteinaemia (HHcy) as an independent risk factor for Coronary Artery Disease (CAD) during recent years. Furthermore, an alanine/valine (Ala/Val) gene polymorphism at 222nd amino acid of 5,10-methylenetetrahydrofolate reductase (MTHFR) has been considered as a factor that could render this enzyme thermolabile and less active which in turn may yield a subsequent increase in plasma total homocysteine (tHcy) levels. To assess whether this polymorphism is associated with increased risk of CAD and plasma levels of tHcy in a population from southern Iran, a total of 457 patients with angiographically documented multi-vessel CAD were compared with a control group comprised of 371 subjects with <30% stenosis in all major vessels. Nevertheless our results failed to admit a significant difference between CAD individuals and control subjects for Ala/Val polymorphism and plasma Hcy concentrations. However, plasma Hcy concentrations were significantly higher in individuals with Val/Val genotype than subjects with Ala/Ala genotype, but it didn't show a significant association with CAD in our population. Moreover, as the multiple linear regression analysis indicated, smoking habit, folate levels and the MTHFR Val/Val genotype were the only major predictors of tHcy concentrations in the current investigation. FAU - Saffari, Babak AU - Saffari B AD - Iranian Academic Center for Education, Culture and Research (ACECR), Fars Province Branch, Shiraz 71347, Iran. FAU - Senemar, Sara AU - Senemar S AD - Iranian Academic Center for Education, Culture and Research (ACECR), Fars Province Branch, Shiraz 71347, Iran. FAU - Karimi, Mehran AU - Karimi M AD - Hematology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz 71937, Iran. FAU - Bahari, Marzieh AU - Bahari M AD - Iranian Academic Center for Education, Culture and Research (ACECR), Fars Province Branch, Shiraz 71347, Iran. FAU - Jooyan, Najmeh AU - Jooyan N AD - Iranian Academic Center for Education, Culture and Research (ACECR), Fars Province Branch, Shiraz 71347, Iran. FAU - Yavarian, Majid AU - Yavarian M AD - Hematology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz 71937, Iran. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Pakistan TA - Pak J Biol Sci JT - Pakistan journal of biological sciences : PJBS JID - 101247723 RN - 0 (Biomarkers) RN - 0LVT1QZ0BA (Homocysteine) RN - EC 1.5.1.20 (MTHFR protein, human) RN - EC 1.5.1.20 (Methylenetetrahydrofolate Reductase (NADPH2)) SB - IM MH - Age of Onset MH - Aged MH - Biomarkers/blood MH - Chi-Square Distribution MH - Coronary Angiography MH - Coronary Artery Disease/blood/diagnostic imaging/enzymology/epidemiology/*genetics MH - Coronary Stenosis/blood/diagnostic imaging/enzymology/epidemiology/*genetics MH - Female MH - Gene Frequency MH - Genetic Predisposition to Disease MH - Homocysteine/*blood MH - Humans MH - Hyperhomocysteinemia/blood/diagnostic imaging/enzymology/epidemiology/*genetics MH - Iran/epidemiology MH - Linear Models MH - Male MH - Methylenetetrahydrofolate Reductase (NADPH2)/*genetics MH - Middle Aged MH - Multivariate Analysis MH - Phenotype MH - *Polymorphism, Single Nucleotide MH - Retrospective Studies MH - Risk Factors EDAT- 2014/02/07 06:00 MHDA- 2014/02/28 06:00 CRDT- 2014/02/07 06:00 PHST- 2014/02/07 06:00 [entrez] PHST- 2014/02/07 06:00 [pubmed] PHST- 2014/02/28 06:00 [medline] AID - 10.3923/pjbs.2013.788.795 [doi] PST - ppublish SO - Pak J Biol Sci. 2013 Aug 15;16(16):788-95. doi: 10.3923/pjbs.2013.788.795.